Crossmark

CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma

Crossref DOI link: https://doi.org/10.15252/embr.202051683

Published Online: 2021-07-23

Published Print: 2021-09-06

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Berico, Pietro https://orcid.org/0000-0001-8034-0790
Cigrang, Max https://orcid.org/0000-0003-2641-9750
Davidson, Guillaume

Braun, Cathy

Sandoz, Jeremy

Legras, Stephanie

Vokshi, Bujamin Hektor https://orcid.org/0000-0002-2161-9836
Slovic, Nevena https://orcid.org/0000-0003-4977-8609
Peyresaubes, François

Gene Robles, Carlos Mario

Egly, Jean‐Marc https://orcid.org/0000-0002-5960-6571
Compe, Emmanuel

Davidson, Irwin https://orcid.org/0000-0001-5533-1171
Coin, Frederic https://orcid.org/0000-0002-5620-8519
Funding

Funding for this research was provided by:

Ligue Contre le Cancer

Agence Nationale de la Recherche (ANR‐10‐LABX‐0030‐INRT)
License Information

Version of Record valid from 2021-07-23
More Information

Publication History

Received: 2020-09-07

Accepted: 2021-06-25

Published: 2021-07-23